Wealth Management Partners’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Wealth Management Partners’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$244K	Buy	+5,586	New	+$258K	0.07%	135

Other funds holding GNOM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

USCWA

U.S. Capital Wealth Advisors Austin, Texas $3.98B AUM 22.36% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

Armis Advisers Atlanta, Georgia $1.09B AUM 22.88% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

CFD

Creative Financial Designs Kokomo, Indiana $1.65B AUM 15.6% 1-Year Est. Return

Wealth Management Partners's GNOM Position: Q1 2026 in Review

Wealth Management Partners opened a new position in Global X Genomics & Biotechnology ETF (GNOM) in Q1 2026: 5,586 shares worth $244K. The stake represents 0.07% of the portfolio and ranks #135 among its holdings.

40 funds tracked by Wall St. Rank hold GNOM as of Q1 2026.

Wealth Management Partners held 5,586 shares of Global X Genomics & Biotechnology ETF worth $244K as of Q1 2026.
Global X Genomics & Biotechnology ETF was a new Wealth Management Partners position in Q1 2026.
Global X Genomics & Biotechnology ETF made up 0.07% of Wealth Management Partners's portfolio in Q1 2026, its #135 holding.
40 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q1 2026.

Based on Wealth Management Partners's 13F filing for Q1 2026, filed 17 Apr 2026.